Ausbiz Capital is now SureStone Capital. Same team, same ABN and AFS authorisations.

ASX: OFXOFX Group LimitedFinancials

OFX Exclusivity With Equals Ends, 2Q27 NOI $45.3m

OFX said exclusivity with Equals ended after its $1.00 per share proposal was not reconfirmed, and reported 2Q27 Net Operating Income of $45.3m, up 3.1%.

By Digifin Pty Ltd · About this coverage

Key Points

  • Transaction Process Deed with Equals terminated and exclusivity ended
  • Discussions continue on a non-exclusive basis
  • 2Q27 Net Operating Income of $45.3m, up 3.1% on 1Q27
  • 1H27 underlying operating expenses expected at $85m to $87m
  • Net Available Cash of $36.6m, down 25.7% on 1Q27
OFX Group Limited (ASX:OFX)

About OFX (ASX:OFX)

OFX Group Limited is an ASX-listed international payments company headquartered in Sydney. It provides money transfers, global business accounts, corporate cards and currency risk management services to business and consumer clients.

OFX (ASX:OFX)'s exclusivity with Equals has ended after the bidder did not reconfirm its $1.00 per share proposal on schedule, and the company also released second quarter trading.

Under the Transaction Process Deed, Alakazam Holdings Bidco Limited (Equals) was scheduled on 23 October 2026 to re-confirm that it did not intend to withdraw or amend its indicative proposal or reduce the $1.00 per share scheme consideration, but did not do so. The deed has terminated and discussions continue on a non-exclusive basis. Net Operating Income for 2Q27 was $45.3m, up 3.1% on 1Q27 and down 9.6% on the pcp. Corporate revenue was $28.4m, up 6.9%, with cross-currency margins up 3bps to 0.6%. High Value Consumer revenue rose 2.8% to $13.3m and Enterprise revenue fell 31.3% to $2.8m. Corporate Active Clients were down 5.0%, or 0.9% excluding Firma and OLS. Non-FX revenue grew to $1.0m, up 31.0% on 1Q27. Underlying operating expenses for 1H27 are expected to be $85m to $87m, including bad debts expense of $3.8m, and OFX executed ~$15m of annualised cost reductions. Net Available Cash was $36.6m, down 25.7% on 1Q27.

There is no certainty that a transaction will proceed, and the release does not say why Equals did not reconfirm. All 2Q27 figures are unaudited and subject to external audit review.

Back to all ASX Company News

Source: OFX Group Limited (ASX:OFX), 26 October 2026. Summary content supplied by Digifin Pty Ltd.

News summary only, not financial advice. It does not consider your objectives, financial situation or needs.

Monday, 26 October 2026

Also summarised today

All ASX Company News
ASX: BSLMaterials

BlueScope Lifts 1H FY27 EBIT Guidance to Near $1.1B

BlueScope now expects 1H FY2027 underlying EBIT approaching $1.1 billion, above its $860–$960 million range, on stronger US steel spreads at North Star.

26 Oct, 8:29 am AEDT
ASX: CGFFinancials

Challenger Board Rejects TDA's $11.80 Indicative Offer

Challenger's Board said TAL Daiichi Life Australia's $11.80 per share indicative offer is not at a level it could recommend, but it intends to keep engaging.

26 Oct, 9:51 am AEDT
ASX: COHHealth Care

Cochlear Holds FY27 Profit Guidance of $330M to $350M

Cochlear reaffirmed FY27 underlying net profit guidance of $330 million to $350 million at its 2026 AGM, after FY26 underlying net profit of $322 million.

26 Oct, 8:33 am AEDT
ASX: INAReal Estate

Ingenia Receives $5.35 Indicative Proposal From AVID

Ingenia received a non-binding AVID proposal of $5.35 cash per stapled security, up to $5.40 with a distribution, and granted up to six weeks' soft exclusivity.

26 Oct, 9:57 am AEDT
ASX: LCLMaterials

LCL Signs Second PNG Farm-In With Rio Tinto at Liamu

LCL Resources signed a binding term sheet under which Rio Tinto may earn up to 80% of the Liamu copper-gold project in PNG, subject to ministerial approval.

26 Oct, 9:02 am AEDT
ASX: LOTEnergy

Lotus Secures Final Permit for First Kayelekera Export

Lotus Resources secured Namibian export approval, completing key permits for its first Kayelekera shipment of approximately 145k lbs of U3O8, due in November.

26 Oct, 9:32 am AEDT
ASX: MYXHealth Care

Mayne Pharma 1Q FY27 Underlying EBITDA Falls to $5.3M

Mayne Pharma reported unaudited 1Q FY27 revenue of $95.7 million and underlying EBITDA of $5.3 million, down 52%, as Dermatology sales fell on generic entry.

26 Oct, 8:49 am AEDT
ASX: RMSMaterials

Ramelius Produces 48,839oz, Holds FY27 Gold Guidance

Ramelius produced 48,839 ounces at an AISC of A$2,656/oz after wet weather slowed Penny haulage, lifted cash and gold to A$768 million and kept FY27 guidance.

26 Oct, 8:26 am AEDT
ASX: SYRMaterials

Syrah Secures US$15M DFC Disbursement for Balama

Syrah Resources will receive a further US$15 million DFC loan disbursement for Balama after DFC temporarily waived existing events of default on the loan.

26 Oct, 9:20 am AEDT

Announcement summaries are published each trading day. General advice only.

Copyright © 2026 SureStone Capital